{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03384108",
            "orgStudyIdInfo": {
                "id": "16-008291"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells",
            "officialTitle": "In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells in Healthy Subjects Using Stable Isotope Resolved Metabolomics: A Pilot Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "in-vivo-assessment-of-glutamine-utilization-by-bone-marrow-plasma-cells"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-11-03",
            "studyFirstSubmitQcDate": "2017-12-22",
            "studyFirstPostDateStruct": {
                "date": "2017-12-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Wilson I. Gonsalves, M.D.",
                "investigatorTitle": "Senior Associate Consultant",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach",
            "detailedDescription": "Twenty healthy adult study participants between the ages of 18 and 60 years will be recruited to participate in this pilot study that will include two groups: a) Ex Vivo group (10 volunteers) and b) In Vivo group (10 volunteers). Volunteers will be recruited to either group in a sequential alternating fashion.\n\nIn vivo 13C SIRM studies evaluating the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "In Vivo vs. Ex Vivo assessment of 5-13C-Glutamine incorporation by plasma cells via a bone marrow aspiration.",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "In Vivo",
                    "type": "EXPERIMENTAL",
                    "description": "Infusion of 5-13C-Glutamine intravenously in healthy subjects prior to undergoing a bone marrow aspiration.",
                    "interventionNames": [
                        "Other: 5-13C-Glutamine",
                        "Other: Bone marrow aspiration"
                    ]
                },
                {
                    "label": "Ex Vivo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Healthy subjects will undergoing a bone marrow aspiration and then the plasma cells acquired will be cultured ex vivo in cell culture media containing 5-13C-Glutamine.",
                    "interventionNames": [
                        "Other: Bone marrow aspiration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "5-13C-Glutamine",
                    "description": "Intravenous infusion of 5-13C-Glutamine",
                    "armGroupLabels": [
                        "In Vivo"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Bone marrow aspiration",
                    "description": "Bone marrow aspiration of bone marrow aspirate",
                    "armGroupLabels": [
                        "Ex Vivo",
                        "In Vivo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of enrichment of 13-Carbon molecules in the TCA cycle metabolites of plasma cells measured by gas chromatography mass spectrometry.",
                    "description": "The plasma cells obtained from the bone marrow aspiration will be processed to determine the percent of 13-carbon enrichment in the various molecules of the TCA cycle within the plasma cells. The outcomes will be reported as a percentage. E.G. 5% of glutamine is labeled with 13-Carbon; e.g. 4% of glutamate is labeled with 13-carbon etc.",
                    "timeFrame": "Through study completion, an average of 1 hour"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ages 18-60\n* Able to provide written consent\n\nExclusion Criteria:\n\n* Renal Failure\n* Pregnancy\n* Active steroid use\n* Active liver Disease\n* Anemia (Hemoglobin \\< 12.5 g/dL in men and \\< 11.5 g/dL in women)\n* H/O alcohol use (average \\> 2 drinks per day)\n* BMI \\> 30",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Wilson Gonsalves",
                    "role": "CONTACT",
                    "phone": "5072842511",
                    "email": "gonsalves.wilson@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Wilson Gonsalves, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Wilson Gonsalves, MD",
                            "role": "CONTACT",
                            "phone": "507-284-2511",
                            "email": "gonsalves.wilson@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "33308307",
                    "type": "DERIVED",
                    "citation": "Gonsalves WI, Jang JS, Jessen E, Hitosugi T, Evans LA, Jevremovic D, Pettersson XM, Bush AG, Gransee J, Anderson EI, Kumar SK, Nair KS. In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells. Cancer Metab. 2020 Dec 11;8(1):29. doi: 10.1186/s40170-020-00235-4."
                }
            ],
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "T6",
                    "name": "Glutamine",
                    "asFound": "Lenvatinib",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}